Prestige Consumer Healthcare PBH
$49.63 +$0.03 (+0.06%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $49.63 0.00%
Open$49.85
Prev close$49.60
Day range$49.43 – $51.23
Volume612.4K
Market cap$2.35B
P/E (TTM)15.3
Dividend yield–
Fundamentals
Latest reported quarter: Q2, ended Sep 2026
Revenue$336.31M+22.7% YoY
Operating profit$80.71M+1.3% YoY
Net profit$25.30M-40.1% YoY
Diluted EPS$0.53-38.4% YoY
Free cash flow$34.24M-38.2% YoY
Operating cash flow$37.87M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin52.5%
Operating margin25.0%
Net margin13.3%
Return on equity8.2%
Return on assets3.8%
Return on invested capital5.9%
Current ratio2.92
Liabilities / assets58.8%
Cash & investments$46.52M
Total debt$2.12B
Net cash (debt)-$2.07B
Free cash flow / sales18.4%
Where the revenue comes from
Quarter 2027/Q2
By business line
Income statement
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $336.31M | $265.71M | $1.09B | $281.62M | $283.44M |
| Total Operating Revenue | $336.31M | $265.71M | $1.09B | $281.62M | $283.44M |
| Cost of Revenue | $163.77M | $129.52M | $493.13M | $135.32M | $126.08M |
| Gross Profit | $172.54M | $136.19M | $595.58M | $146.30M | $157.37M |
| Operating Expense | $91.83M | $83.67M | $286.17M | $70.81M | $74.88M |
| Selling and Admin Expenses | $83.12M | $77.97M | $265.23M | $65.37M | $69.73M |
| -Selling & Marketing Expense | $52.23M | $34.67M | $148.78M | $35.09M | $40.06M |
| -General & Admin Expense | $30.89M | $43.30M | $116.45M | $30.28M | $29.67M |
| Depreciation & Amortization & Depletion | $8.71M | $5.70M | $20.94M | $5.44M | $5.15M |
| -Depreciation & Amortization | $8.71M | $5.70M | $20.94M | $5.44M | $5.15M |
| Operating Profit | $80.71M | $52.52M | $309.41M | $75.49M | $82.49M |
| Net Non-Operating Interest Income (Expense) | -$30.03M | -$13.95M | -$42.34M | -$11.43M | -$10.67M |
| Non-Operating Interest Expense | $30.03M | $13.95M | $42.34M | $11.43M | $10.67M |
| Other Income (Expense) | -$3.24M | -$34,000.00 | -$9.57M | $708,000.00 | -$10.01M |
| Special Income (Charges) | -$1.36M | – | $0.00 | – | – |
| -Less:Other Special Charges | $1.36M | – | – | – | – |
| Other Non-Operating Income (Expenses) | -$1.88M | -$34,000.00 | -$9.57M | $708,000.00 | -$10.01M |
| Pretax Profit | $47.45M | $38.54M | $257.50M | $64.77M | $61.81M |
| Tax | $22.16M | $9.36M | $67.20M | $10.84M | $15.12M |
| Net Profit | $25.30M | $29.18M | $190.30M | $53.93M | $46.70M |
| Profit from Continuing Operations | $25.30M | $29.18M | $190.30M | $53.93M | $46.70M |
| Net Income to Parent Company | $25.30M | $29.18M | $190.30M | $53.93M | $46.70M |
| Net Income to Common Stockholders | $25.30M | $29.18M | $190.30M | $53.93M | $46.70M |
| Basic EPS | $0.53 | $0.61 | $3.93 | $1.14 | $0.98 |
| Diluted EPS | $0.53 | $0.61 | $3.91 | $1.13 | $0.97 |
| -Less:Impairment of Capital Assets | – | – | $0.00 | – | – |
Balance sheet
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Total Assets | $4.72B | $4.57B | $3.49B | $3.49B | $3.49B |
| Total Current Assets | $492.13M | $496.81M | $431.48M | $431.48M | $433.43M |
| Cash and Cash Equivalents & Short-Term Investments | $46.52M | $89.13M | $63.87M | $63.87M | $62.37M |
| -Cash and Cash Equivalents | $46.52M | $89.13M | $63.87M | $63.87M | $62.37M |
| Receivables | $244.12M | $187.36M | $191.92M | $191.92M | $190.46M |
| -Accounts Receivable | $244.12M | $187.36M | $208.57M | $208.57M | $190.46M |
| Inventory | $179.20M | $190.22M | $159.13M | $159.13M | $163.59M |
| Other Current Assets | $22.29M | $30.12M | $16.56M | $16.56M | $17.01M |
| Total Non-Current Assets | $4.23B | $4.07B | $3.06B | $3.06B | $3.06B |
| Net PPE | $161.63M | $164.17M | $171.25M | $171.25M | $174.74M |
| -Gross PPE | $161.63M | $164.17M | $260.11M | $260.11M | $174.74M |
| Goodwill and Other Intangible Assets | $4.06B | $3.89B | $2.88B | $2.88B | $2.88B |
| -Goodwill | $705.26M | $650.80M | $581.11M | $581.11M | $581.25M |
| -Other Intangible Assets | $3.36B | $3.24B | $2.30B | $2.30B | $2.30B |
| Other Non-Current Assets | $5.59M | $13.43M | $10.87M | $10.87M | $3.79M |
| Total Liabilities | $2.78B | $2.65B | $1.61B | $1.61B | $1.67B |
| Total Current Liabilities | $168.50M | $153.81M | $120.92M | $120.92M | $139.56M |
| Payables | $44.90M | $44.42M | $23.52M | $23.52M | $43.41M |
| -Accounts Payable | $44.02M | $36.85M | $22.79M | $22.79M | $42.95M |
| -Total Tax Payable | $882,000.00 | $7.57M | $733,000.00 | $733,000.00 | $466,000.00 |
| Current Accrued Expenses | $99.35M | $77.99M | $72.72M | $72.72M | $77.10M |
| Short-Term Debt and Capital Lease Obligation | $13.83M | $23.80M | $12.55M | $12.55M | $8.63M |
| -Current Debt | $3.87M | $14.09M | $2.99M | $2.99M | – |
| -Current Capital Lease Obligation | $9.96M | $9.71M | $9.57M | $9.57M | $8.63M |
| Total Non-Current Liabilities | $2.61B | $2.50B | $1.49B | $1.49B | $1.53B |
| Long Term Debt and Capital Lease Obligation | $2.11B | $2.04B | $1.03B | $1.03B | $1.07B |
| -Long Term Debt | $2.08B | $2.01B | $993.95M | $993.95M | $1.03B |
| -Long Term Capital Lease Obligation | $34.09M | $36.41M | $38.92M | $38.92M | $37.11M |
| Non-Current Deferred Liabilities | $489.53M | $448.82M | $447.42M | $447.42M | $449.33M |
| Other Non-Current Liabilities | $5.55M | $5.59M | $5.58M | $5.58M | $5.75M |
| Total Equity | $1.94B | $1.92B | $1.89B | $1.89B | $1.83B |
| Stockholders' Equity | $1.94B | $1.92B | $1.89B | $1.89B | $1.83B |
| Capital Stock | $563,000.00 | $563,000.00 | $562,000.00 | $562,000.00 | $562,000.00 |
| -Common Stock | $563,000.00 | $563,000.00 | $562,000.00 | $562,000.00 | $562,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $613.84M | $612.51M | $608.52M | $608.52M | $605.50M |
| Retained Earnings | $1.80B | $1.78B | $1.75B | $1.75B | $1.69B |
| Less: Treasury Stock | -$441.99M | -$441.96M | -$439.30M | -$439.30M | -$438.55M |
| Gains/Losses Not Affecting Retained Earnings | -$28.33M | -$29.68M | -$28.37M | -$28.37M | -$30.23M |
| -Loans Receivable | – | – | $0.00 | $0.00 | – |
| -Other Receivables | – | – | $1.54M | $1.54M | – |
| -Receivables Adjustments Allowances | – | – | -$18.19M | -$18.19M | – |
| -Accumulated Depreciation | – | – | -$88.87M | -$88.87M | – |
Cash flow
| Line item | 2027 Q2 | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $37.87M | $70.79M | $257.63M | $42.84M | $78.29M |
| Net cash flow from continuing operations | $37.87M | $70.79M | $257.63M | $42.84M | $78.29M |
| Net Income from Continuing Operations | $25.30M | $29.18M | $190.30M | $53.93M | $46.70M |
| Gain/Loss from Continuing Operations | $1.50M | $191,000.00 | $165,000.00 | $25,000.00 | $9,000.00 |
| Depreciation & Depletion & Amortization | $11.96M | $8.75M | $31.27M | $8.35M | $7.59M |
| Deferred Tax | $15.27M | $193,000.00 | $22.70M | -$4.11M | $3.60M |
| Other Non-Cash Items | $18.11M | $5.40M | $19.98M | $2.49M | $12.72M |
| Change in Working Capital | -$35.51M | $23.09M | -$17.62M | -$20.49M | $4.94M |
| -Change in Receivables | -$48.84M | $3.45M | -$3.69M | -$1.60M | $495,000.00 |
| -Change in Inventory | $6.39M | -$2.83M | -$1.60M | $5.47M | $3.21M |
| -Change in Prepaid Assets | -$7.74M | $1.56M | -$6.97M | -$55,000.00 | $4.85M |
| -Change in Payables and Accrued Expense | $16.79M | $23.23M | $2.38M | -$22.44M | -$1.65M |
| -Change in Other Current Liabilities | -$2.09M | -$2.10M | -$7.78M | -$2.00M | -$1.94M |
| -Change In Other Working Capital | -$23,000.00 | -$233,000.00 | $32,000.00 | $128,000.00 | -$25,000.00 |
| Net cash flow from investing | -$138.90M | -$1.06B | -$136.84M | -$3.41M | -$128.56M |
| Net Cash Flow from Continuing Investing Activities | -$138.90M | -$1.06B | -$136.84M | -$3.41M | -$128.56M |
| Net PPE Purchase and Sale | -$3.62M | -$3.70M | -$11.18M | -$5.21M | -$3.03M |
| Net Business Purchase and Sale | -$148.56M | -$1.05B | -$123.74M | $1.80M | -$125.53M |
| Net Other Investing Changes | $13.28M | -$15.03M | -$1.93M | $0.00 | $0.00 |
| Financing Cash Flow | $58.30M | $1.02B | -$156.06M | -$38.10M | -$6.73M |
| Net Cash Flow from Continuing Financing Activities | $58.30M | $1.02B | -$156.06M | -$38.10M | -$6.73M |
| Net Issuance Payments Of Debt | $64.58M | $1.05B | $504,000.00 | -$37.73M | $39.38M |
| Net Common Stock Issuance | $0.00 | $0.00 | -$156.28M | -$690,000.00 | -$45.82M |
| Proceeds from Stock Option Exercised | $94,000.00 | $0.00 | $4.29M | $378,000.00 | $0.00 |
| Net Other Financing Charges | -$6.38M | -$26.62M | -$4.57M | -$62,000.00 | -$290,000.00 |
| Ending Cash Balance | $46.52M | $89.13M | $63.87M | $63.87M | $62.37M |
| Net Change in Cash | -$42.74M | $25.51M | -$35.28M | $1.33M | -$57.01M |
| Beginning Cash Balance | $89.13M | $63.87M | $97.88M | $62.37M | $119.11M |
| Effect of Exchange Rate Changes | $130,000.00 | -$246,000.00 | $1.26M | $167,000.00 | $272,000.00 |
| Free Cash Flow | $34.24M | $67.09M | $246.45M | $37.63M | $75.26M |
No comments yet — be the first to weigh in on PBH.
Sign in to join the discussion.